Rowlandmiller & Partners’s GE HealthCare GEHC Stock Holding History

Rowlandmiller & Partners’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,295	Closed	-$106K	–	194
2025 Q4	$106K	Buy	+1,295	New	+$101K	0.02%	194
2025 Q2	–	Sell	-1,295	Closed	-$105K	–	190
2025 Q1	$105K	Hold	1,295	–	–	0.02%	183
2024 Q4	$101K	Sell	1,295 -2	-0.2%	-$170	0.02%	183
2024 Q3	$122K	Buy	1,297 +2	+0.2%	+$168	0.02%	169
2024 Q2	$101K	Hold	1,295	–	–	0.02%	176
2024 Q1	$118K	Hold	1,295	–	–	0.02%	171
2023 Q4	$100K	Buy	+1,295	New	+$90.7K	0.02%	179
2023 Q3	–	Sell	-1,314	Closed	-$107K	–	177
2023 Q2	$107K	Sell	1,314 -49	-4%	-$3.91K	0.03%	173
2023 Q1	$112K	Buy	+1,363	New	+$97.3K	0.03%	173

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Rowlandmiller & Partners's GEHC Position: Q1 2026 in Review

Rowlandmiller & Partners sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 1,295 shares — an estimated $106K sold.

Rowlandmiller & Partners first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $122K in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Rowlandmiller & Partners reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Rowlandmiller & Partners sold 1,295 GE HealthCare shares in Q1 2026, an estimated $106K.
Rowlandmiller & Partners first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
Rowlandmiller & Partners's GE HealthCare position peaked at $122K in Q3 2024.
1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Rowlandmiller & Partners's 13F filing for Q1 2026, filed 1 Apr 2026.